Rxcurve
HCPCS J1455 · per 1000 MG

Foscarnet sodium injection

Products billed under this code include Foscarnet Sodium.

Payment limit per 1000 MG, by effective quarter, 1Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1455

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Foscarnet Sodium Hikma Pharmaceuticals USA Inc. 00143-9192-01 60 $404.04
Foscarnet Sodium Sagent Pharmaceuticals 25021-0189-84 60 $404.04
Foscarnet Sodium Baxter Healthcare Corporation 43066-0089-10 60 $404.04
Foscarnet Sodium FreseniUS Kabi USA, LLC 63323-0875-50 6 $40.404
Foscarnet Sodium Amneal Pharmaceuticals, LLC 70121-1744-02 72 $484.848

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $6.734 −$1.621 1000 MG Foscarnet sodium injection v1, posted September 17, 2026
3Q26 $8.355 −$0.001 1000 MG Foscarnet sodium injection v1, posted September 15, 2026
2Q26 $8.356 +$1.646 1000 MG Foscarnet sodium injection v1, posted September 15, 2026
1Q26 $6.71 −$9.367 1000 MG Foscarnet sodium injection v1, posted September 15, 2026
4Q25 $16.077 +$0.493 1000 MG Foscarnet sodium injection v1, posted September 8, 2026
3Q25 $15.584 −$6.045 1000 MG Foscarnet sodium injection v1, posted March 10, 2026
2Q25 $21.629 −$16.648 1000 MG Foscarnet sodium injection v1, posted March 10, 2026
1Q25 $38.277 – 1000 MG Foscarnet sodium injection v1, posted December 19, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files